What is the latest price of bedaquiline on the market in 2025?

Bedaquiline(Bedaquiline) is a new type of anti-tuberculosis drug, mainly used to treat multi-drug-resistant tuberculosis disease (MDR-TB). In recent years, with the increase in drug-resistant tuberculosis, traditional treatment options have faced severe challenges, and the emergence of bedaquiline has brought new hope to this field. Bedaquiline can effectively block the energy metabolism of bacteria by selectively inhibiting the ATP synthase of Mycobacterium tuberculosis, thus exerting antibacterial effects.

In China, bedaquiline fumarate tablets have recently been approved for marketing and included in medical insurance, providing patients with a more affordable treatment option. The common specifications are 100mg per box, containing 24 tablets, and the price is about 10,000 yuan. Although the price is relatively high, it is acceptable to a certain extent considering its efficacy in treating multidrug-resistant tuberculosis. Medicare coverage allows more patients to obtain this important drug, reducing the financial burden.

In overseas markets, bedaquiline has also received attention, especially in some countries and regions where drug-resistant tuberculosis is endemic. In the market of some countries, the specifications of bedaquiline may reach 188 tablets of 100 mg, and the price may be as high as 10,000 yuan. The specific selling price is affected by exchange rate fluctuations. In addition, with the successful application of bedaquiline, multiple generic versions have appeared on the market. The ingredients of these generic drugs are basically the same as those of the original drugs, and the prices are relatively more affordable. For example, bedaquiline generics produced by some pharmaceutical companies in India may be sold for more than 2,000 yuan per box of 188 tablets, which greatly reduces the financial pressure on patients.

Overall, the launch of bedaquiline provides a new treatment option for patients with drug-resistant tuberculosis, and its unique mechanism and efficacy make it widely used around the world. Although price differences exist at home and abroad, with the launch of generic drugs, market competition is expected to further reduce patients' treatment costs and improve patients' treatment compliance.

Reference materials:https://en.wikipedia.org/wiki/Bedaquiline